Cytocom Inc CBLI:NASDAQ

RT Quote | NASDAQ | USD
Last | 07/30/21 EDT
4.24quote price arrow down-0.12 (-2.75%)
Volume
153,489
52 week range
1.62 - 10.97

...

Loading . . .
  • Open4.35
  • Day High4.60
  • Day Low4.23
  • Prev Close4.36
  • 52 Week High10.97
  • 52 Week High Date02/18/21
  • 52 Week Low1.62
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap65.59M
  • Shares Out15.47M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change24.64

KEY STATS

  • Open4.35
  • Day High4.60
  • Day Low4.23
  • Prev Close4.36
  • 52 Week High10.97
  • 52 Week High Date02/18/21
  • 52 Week Low1.62
  • 52 Week Low Date09/04/20
  • Market Cap65.59M
  • Shares Out15.47M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change24.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.18
  • P/E (TTM)-23.48
  • Fwd P/E (NTM)-32.62
  • EBITDA (MRQ)-2.683M
  • ROE (MRQ)-93.81%
  • Revenue (MRQ)110,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,229.31%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cytocom Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Cytocom, Inc., formerly Cleveland BioLabs, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing small molecule immunotherapies, which targets autoimmune, inflammatory, infectious diseases and cancers. Its advanced immunomodulating multi-receptor system (AIMS) platform is a drug discovery and development platform, which is designed to restore immune homeostasis. Its immunomodulatory drugs are developed using AIMS platform, which adjusts...
Lea Verny
Chairman
Christopher Zosh
Chief Executive Officer
Langdon Miller M.D.
President
Address
73 High St
Buffalo, NY
14203-1149
United States

Top Peers

SYMBOLLASTCHG%CHG
PRPO
Precipio Inc
3.11+0.06+1.97%
RGLS
Regulus Therapeutics Inc
0.7039-0.0096-1.3455%
APVO
Aptevo Therapeutics Inc
18.77+0.10+0.54%
ISR
IsoRay Inc
0.6863-0.0122-1.7466%
CDTX
Cidara Therapeutics Inc
1.52+0.04+2.70%
YMTX
Yumanity Therapeutics Inc
9.16-0.28-2.97%